Efthymia Bazani

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.

Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report.

Journal: OncoTargets and therapy

Published: August 14, 2020

Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group.

Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group.

Journal: Hematological oncology

Published: June 30, 2020

Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.

Prognostic significance of monoclonal gammopathy in diffuse large B-cell lymphoma.

Journal: Hematological oncology

Published: July 16, 2019

Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience.

Coexistence of Myeloid and Lymphoid Neoplasms: A Single-Center Experience.

Journal: Advances in hematology

Published: May 01, 2019

MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.

MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: June 19, 2018

Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: October 18, 2017

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.

MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.

Journal: Disease markers

Published: September 26, 2017

Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study.

Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 29, 2015

CNS Involvement in AML Patient Treated with 5-Azacytidine.

CNS Involvement in AML Patient Treated with 5-Azacytidine.

Journal: Case reports in hematology

Published: April 12, 2014

Showing 1-9 of 9

Last Updated: 09/26/2026